These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25754526)

  • 1. Dynamic contrast-enhanced ultrasound parametric imaging for the detection of prostate cancer.
    Postema AW; Frinking PJ; Smeenge M; De Reijke TM; De la Rosette JJ; Tranquart F; Wijkstra H
    BJU Int; 2016 Apr; 117(4):598-603. PubMed ID: 25754526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-D Quantitative Dynamic Contrast Ultrasound for Prostate Cancer Localization.
    Schalk SG; Huang J; Li J; Demi L; Wijkstra H; Huang P; Mischi M
    Ultrasound Med Biol; 2018 Apr; 44(4):807-814. PubMed ID: 29395678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
    Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
    Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
    Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
    BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
    Beer L; Polanec SH; Baltzer PAT; Schatzl G; Georg D; Schestak C; Dutschke A; Herrmann H; Mazal P; Brendel AK; Shariat SF; Ringl H; Helbich TH; Apfaltrer P
    PLoS One; 2019; 14(12):e0225673. PubMed ID: 31856177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
    Cornelis F; Rigou G; Le Bras Y; Coutouly X; Hubrecht R; Yacoub M; Pasticier G; Robert G; Grenier N
    Radiology; 2013 Oct; 269(1):159-66. PubMed ID: 23657887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?
    Schmuecking M; Boltze C; Geyer H; Salz H; Schilling B; Wendt TG; Kloetzer KH; Marx C
    Int J Radiat Biol; 2009 Sep; 85(9):814-24. PubMed ID: 19701842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer.
    Wildeboer RR; Postema AW; Demi L; Kuenen MPJ; Wijkstra H; Mischi M
    Eur Radiol; 2017 Aug; 27(8):3226-3234. PubMed ID: 28004162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR-guided prostate biopsy for planning of focal salvage after radiation therapy.
    Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA
    Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
    Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
    Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.
    Hara N; Okuizumi M; Koike H; Kawaguchi M; Bilim V
    Prostate; 2005 Feb; 62(2):140-7. PubMed ID: 15389803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep neural maps for unsupervised visualization of high-grade cancer in prostate biopsies.
    Sedghi A; Pesteie M; Javadi G; Azizi S; Yan P; Kwak JT; Xu S; Turkbey B; Choyke P; Pinto P; Wood B; Rohling R; Abolmaesumi P; Mousavi P
    Int J Comput Assist Radiol Surg; 2019 Jun; 14(6):1009-1016. PubMed ID: 30905010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical value of dynamic contrast-enhanced magnetic resonance imaging at 3.0T to detect prostate cancer.
    Zhang X; Quan X; Lu S; Huang F; Yang J; Chan Q; Lin T
    J Int Med Res; 2014 Oct; 42(5):1077-84. PubMed ID: 25091389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.
    Lattouf JB; Grubb RL; Lee SJ; Bjurlin MA; Albert P; Singh AK; Ocak I; Choyke P; Coleman JA
    BJU Int; 2007 May; 99(5):1041-6. PubMed ID: 17437438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transabdominal contrast-enhanced ultrasound imaging of the prostate.
    Mischi M; Demi L; Smeenge M; Kuenen MP; Postema AW; de la Rosette JJ; Wijkstra H
    Ultrasound Med Biol; 2015 Apr; 41(4):1112-8. PubMed ID: 25701535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology.
    Jia JB; Houshyar R; Verma S; Uchio E; Lall C
    Eur J Radiol; 2016 Jan; 85(1):261-267. PubMed ID: 26526901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.